Biovica International AB (publ) (STO:BIOVIC.B)
0.3020
+0.0040 (1.34%)
Oct 13, 2026, 1:55 PM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 88.16 million as of October 12, 2026. It is the 42,419th most valuable company in the world and the 619th biggest in Sweden. Its market cap has decreased by 45.17% in one year.
Market Cap
88.16M
Enterprise Value
42.59M
Revenue
14.93M
Global Rank
Country Rank
#619 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 88.16M, a decrease of -58.02%. That is a compound annual growth rate of -8.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 88.16M | -18.38% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 127.91M |
| Initiator Pharma | 123.22M |
| OncoZenge AB | 115.37M |
| Ascelia Pharma AB | 114.84M |
| Active Biotech AB | 92.79M |
| Nanologica AB | 91.07M |
| Alzinova AB | 87.95M |
| Spago Nanomedical AB | 81.04M |